Isfahan University of Medical Sciences

Science Communicator Platform

Share By
Atorvastatin and Flaxseed Effects on Biochemical Indices and Hepatic Fat of Nafld Model in Rats Publisher

Summary: ATO and flaxseed may help improve lipid profiles in NAFLD, potentially reducing complications. Could this be a new treatment approach? #LiverHealth #NAFLD

Eslami Z ; Moghanlou A ; Kandi Y ; Sheikh Arabi M ; Nourozi A ; Joshaghani H
Authors

Source: Advanced Biomedical Research Published:2023


Abstract

Background: Non-alcoholic fatty liver disease (NAFLD) is one of the most common forms of chronic liver disease that affects about 25% of the general population. No definitive treatment for NAFLD has been identified yet. The aim was to determine the effect of atorvastatin (ATO) and flaxseed on related indicators of NAFLD-induced fat/fructose-enriched diet (FFD). Materials and Methods: Forty male Wistar rats were divided into five groups. NAFLD groups received FFD and carbon tetrachloride (CCl4) to induce NAFLD. After intervention with ATO (10 mg/kg/day) and/or flaxseed (7.5 g/kg/day), liver enzymes and lipid profiles in serum were determined at eight week of interventions. Results: Triglycerides (TG) and cholesterol (CHO) in FFD + ATO, FFD + flaxseed, and FFD + ATO + flaxseed had a significant decrease and low-density lipoprotein (LDL) level and LDL/high-density lipoprotein (HDL) ratio showed a significant increase in the FFD + flaxseed compared to the FFD. The levels of aspartate transaminase (AST), alanine transaminase (ALT), and gamma-glutamyltransferase (GGT) were significantly reduced in the FFD + ATO, FFD + flaxseed, and the FFD + ATO + flaxseed. In addition, Alkaline phosphatase (ALP) levels were significantly different between normal and FFD. Fasting blood sugar (FBS) levels were significantly different in the FFD + flaxseed and the FFD + ATO + flaxseed compared to the FFD. Conclusion: ATO therapy along with flaxseed controls NAFLD-related indices and FBS. Therefore, it can be stated with caution that ATO and flaxseed can be used to improve lipid profile and reduce the complications of NAFLD. © 2023 Elsevier B.V., All rights reserved.
Related Docs
View other Related Docs
1. The Effect of a Mediterranean Diet on Metabolic Parameters in Patients With Non-Alcoholic Fatty Liver Disease: A Systematic Review of Randomized Controlled Trials, Clinical Nutrition ESPEN (2020)
2. Sesame Oil Ameliorates Alanine Aminotransferase, Aspartate Aminotransferase, and Fatty Liver Grade in Women With Nonalcoholic Fatty Liver Disease Undergoing Low-Calorie Diet: A Randomized Double-Blind Controlled Trial, International journal of clinical practice (2022)
3. Potential Synergistic Effects of Caffeine and Naringin on Mitochondrial Biogenesis and Hepatic Steatosis in Adult Male Rats With Nafld Induced by a High-Fat Diet, BioMed Research International (2025)
Experts (# of related papers)
View all Related Experts
Peyman Adibi (2)
Mohammad Hassan Entezari (1)
Atorvastatin and Flaxseed Effects on Biochemical Indices and Hepatic Fat of Nafld Model in Rats
Other Related Docs
4. Diet Macronutrients Composition in Nonalcoholic Fatty Liver Disease: A Review on the Related Documents, Hepatitis Monthly (2014)
5. Effects of Flaxseed Supplementation on Inflammatory Biomarkers: A Grade-Assessed Systematic Review and Meta-Analysis of Randomized Controlled Trials, Prostaglandins and Other Lipid Mediators (2024)
6. Dietary Quality Indices and Biochemical Parameters Among Patients With Non Alcoholic Fatty Liver Disease (Nafld), Hepatitis Monthly (2013)
7. The Effect of Curcumin Pill in Treatment of Non-Alcoholic Fatty Liver Disease: A Clinical Trial Study, Journal of Isfahan Medical School (2017)
8. Effects of Flaxseed on Blood Lipids in Healthy and Dyslipidemic Subjects: A Systematic Review and Meta-Analysis of Randomized Controlled Trials, Current Problems in Cardiology (2022)
9. Adherence to Low Carbohydrate Diets and Non-Alcoholic Fatty Liver Disease: A Case Control Study, BMC Nutrition (2022)
10. The Efficacy of Vitamin D Supplementation Against Nonalcoholic Fatty Liver Disease: A Meta-Analysis, Journal of Dietary Supplements (2020)
11. The Effects of Sumac (Rhus Coriaria L.) Powder Supplementation in Patients With Non-Alcoholic Fatty Liver Disease: A Randomized Controlled Trial, Complementary Therapies in Clinical Practice (2020)
12. Effect of Pioglitazone on Nonalcoholic Fatty Liver Disease in Morbid Obese Patients; a Randomized Controlled Trial, Advanced Biomedical Research (2023)